Evidence map›Paper›PMID 35335094›Full record

ArticleVaccines2022

Whole Proteome-Based Therapeutic Targets Annotation and Designing of Multi-Epitope-Based Vaccines against the Gram-Negative XDR-

Metab Alharbi, Abdulrahman Alshammari, Abdullah F Alasmari, Saud Alharbi, Muhammad Tahir Ul Qamar, Sumra Wajid Abbasi, Bilal Shaker, Sajjad Ahmad

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. An integrated multi-pronged reverse vaccinology and biophysical approaches for identification of potential vaccine candidates against Nipah virus.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Metab AlharbiDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Abdulrahman AlshammariDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Abdullah F AlasmariDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-7569-4287
Saud AlharbiMinistry of Health, Riyadh 11451, Saudi Arabia.
Muhammad Tahir Ul QamarDepartment of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.ORCID 0000-0003-4832-4250
Sumra Wajid AbbasiNUMS Department of Biological Sciences, National University of Medical Sciences, Rawalpindi 46000, Pakistan.ORCID 0000-0002-4998-937X
Bilal ShakerDepartment of Biomedical Engineering, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea.
Sajjad AhmadDepartment of Health and Biological Sciences, Abasyn University, Peshawar 25000, Pakistan.ORCID 0000-0003-0754-1742
King Saud University · SAAbasyn University · PKChung-Ang University · KRGovernment College University, Faisalabad · PKMinistry of Health · SANational University of Medical Sciences · PK

Funding

King Saud University RSP2022R462
6 · The paper itself

Abstract

This study involved therapeutic targets mining for the extremely drug-resistant bacterial species called

Indexed as

Alcaligenes faecalisepitopesin silico cloningmolecular dockingsubtractive proteomics

Identifiers

PMID35335094
PMCPMC8955209
OpenAlexW4221056131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.